Skip to main content
. 2016 Dec 1;13(1):69–76. doi: 10.3892/ol.2016.5456

Figure 1.

Figure 1.

The mechanism of action for the novel radiosensitizer KORTUC II. Antioxidant enzymes in the tumors are inactivated and plentiful oxygen is produced; in this way, radioresistant cancers can be made radiosensitive. KORTUC II, Kochi Oxydol Radiation Therapy for Unresectable Carcinomas II.